Changes in the fatty acid composition of the liver with the administration of n-3 polyunsaturated fatty acids and the effects on warm ischemia/reperfusion injury in the rat liver

Shock

Volumn 33, Issue 3, 2010, Pages 306-314

  Iwasaki, Wataru ^a   Kume, Makoto ^a   Kudo, Kazuhiro ^a   Uchinami, Hiroshi ^a   Kikuchi, Isao ^a   Nakagawa, Yasuhiko ^a   Yoshioka, Masato ^a   Yamamoto, Yuzo ^a  

^a AKITA UNIVERSITY   (Japan)

Author keywords

Anti inflammatories; Cyclic AMP; Cyclooxygenase; Hepatic microcirculation; Prostaglandin

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CYCLIC AMP; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; CYTOKINE; INTERLEUKIN 6; MESSENGER RNA; MYELOPEROXIDASE; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; POLYUNSATURATED FATTY ACID; PROSTAGLANDIN E2; THROMBOXANE B2; TUMOR NECROSIS FACTOR ALPHA;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD LEVEL; CONTROLLED STUDY; CYTOKINE RELEASE; DIET SUPPLEMENTATION; FATTY ACID ANALYSIS; GAS CHROMATOGRAPHY; HISTOLOGY; LIVER; LIVER CIRCULATION; LIVER FUNCTION; LIVER ISCHEMIA; MALE; MICROCIRCULATION; NONHUMAN; NUTRITIONAL STATUS; RAT; REPERFUSION INJURY;

ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DINOPROSTONE; FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FATTY ACIDS, UNSATURATED; INTERLEUKIN-6; LIVER; MALE; RATS; RATS, WISTAR; REPERFUSION INJURY; RNA, MESSENGER; THROMBOXANE B2; TUMOR NECROSIS FACTOR-ALPHA;

EID: 77149121418     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3181b2ffd2     Document Type: Article

References (34)

1. Jaeschke H: Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 284:G15-G26, 2003. (Pubitemid 36076246)
2. Nakamura K, Kariyazono H, Komokata T, Hamada N, Sakata R, Yamada K: Influence of preoperative administration of 5-13 fatty acidYenriched supplement on inflammatory and immune responses in patients undergoing major surgery for cancer. Nutrition 21:639-649, 2005.
3. Gianotti L, Braga M, Nespoli L, Radaelli G, Beneduce A, Di Carlo V: A randomized controlled trial of preoperative oral supplementation with a specialized diet in patients with gastrointestinal cancer. Gastroenterology 122:1763-1770, 2002.
4. Heller AR, Rössler S, Litz RJ, Stehr SN, Heller SC, Koch R, Koch T: Omega-3 fatty acids improve the diagnosis-related clinical outcome. Crit Care Med 34:972-979, 2006.
5. Botham KM, Mayes PA: Biosynthesis of fatty acids & eicosanoids. In: Murray RK, Granner DK, Rodwell VW, (eds.): Harper's Illustrated Biochemistry. 27th ed. New York: The McGraw-Hill Companies, Inc., 196-208, 2006.
6. Bagga D, Wang L, Farias-Eisner R, Glaspy JA, Reddy ST: Differential effects of prostaglandin derived from 5-6 and 5-3 polyunsaturated fatty acids on COX-2 expression and IL-6 secretion. Proc Natl Acad Sci USA 100: 1751-1756, 2003.
7. Narumiya S, Sugimoto Y, Ushikubi F: Prostanoid receptors: structures, properties, and functions. Physiol Rev 79:1193-1226, 1999.
8. Wada M, DeLong CJ, Hong YH, Rieke CJ, Song I, Sidhu RS, Yuan C, Warnock M, Schmaier AH, Yokoyama C, et al.: Enzymes and receptors of prostaglandin pathways with arachidonic acid-derived versus eicosapentaenoic acidYderived substrates and products. J Biol Chem 282:22254-22266, 2007.
9. Abayasekara DRE, Wathes DC: Effects of altering dietary fatty acid composition on prostaglandin synthesis and fertility. Prostaglandins Leukot Essent Fatty Acids 61:275-287, 1999.
10. Miyagi S, Ohkohchi N, Oikawa K, Satoh M, Tsukamoto S, Satomi S: Effects of anti-inflammatory cytokine agent (FR167653) and serine protease inhibitor on warm ischemia-reperfusion injury of the liver graft. Transplantation 77: 1487-1493, 2004.
11. Hamada T, Tsuchihashi S, Avanesyan A, Duarte S, Moore C, Busuttil RW, Coito AJ: Cyclooxygenase-2 deficiency enhances Th2 immune responses and impairs neutrophil recruitment in hepatic ischemia/reperfusion injury. J Immunol 180:1843-1853, 2008.
12. El-Badry AM, Moritz W, Contaldo C, Tian Y, Graf R, Clavien P-A: Prevention of reperfusion injury and microcirculatory failure in macrosteatotic mouse liver by omega-3 fatty acids. Hepatology 45:855-863, 2007.
13. Folch J, Lees M, Sloane Stanley GH: A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 226:497-509, 1957.
14. Ohta M, Kishihara F, Hashizume M, Kawanaka H, Tomikawa M, Higashi H, Tanoue K, Sugimachi K: Increased prostacyclin content in gastric mucosa of cirrhotic patients with portal hypertensive gastropathy. Prostaglandins Leukot Essent Fatty Acids 53:41-45, 1995.
15. Moaveni DK, Lynch EM, Luke C, Sood V, Upchurch GR, Wakefield TW, Henke PK: Vein wall re-endothelialization after deep vein thrombosis is improved with low-molecular-weight heparin. J Vasc Surg 47:616-624, 2008.
16. Helmer KS, Cui Y, Chang L, Dewan A, Mercer DW: Effects of ketamine/ xylazine on expression of tumor necrosis factorY!, inducible nitric oxide synthase, and cyclo-oxygenaseY2 in rat gastric mucosa during endotoxemia. Shock 20:63-69, 2003.
17. Nakano Y, Kondo T, Matsuo R, Hashimoto I, Kawasaki T, Kohno K, Nyronovych A, Tadano S, Hisakura K, Ikeda O, et al.: Platelet dynamics in the early phase of postischemic liver in vivo. J Surg Res 149:192-198, 2008.
18. Coimbra R, Porcides RD, Melbostad H, Loomis W, Tobar M, Hoyt DB, Wolf P: Nonspecific phosphodiesterase inhibition attenuates liver injury in acute endotoxemia. Surg Infect (Larchmt) 6:73-85, 2005.
19. Senkal M, Geier B, Hannemann M, Deska T, Linseisen J, Wolfram G, Adolph M: Supplementation of 5-13 fatty acids in parenteral nutrition beneficially alters phospholipid fatty acid pattern. JPEN J Parenter Enteral Nutr 31:12-17, 2007.
20. Käkelä R, Hyvärinen H: Composition of polyunsaturated fatty acids in the liver of freshwater and marine ringed seals (Phoca hispida ssp.) differs largely due to the diet of the seals. Comp Biochem Physiol B Biochem Mol Biol 120:231-237, 1998.
21. Simopoulos AP: Human requirement for N-3 polyunsaturated fatty acids. Poult Sci 79:961-970, 2000.
22. Okamoto T, Hino O: Expression of cyclooxygenase-1 and-2 mRNA in rat tissues: tissue-specific difference in the expression of the basal level of mRNA. Int J Mol Med 6:455-457, 2000.
23. Sunose Y, Takeyoshi I, Ohwada S, Tsutsumi H, Iwazaki S, Kawata K, Kawashima Y, Tomizawa N, Matsumoto K, Morishita Y: The effect of cyclooxygenase-2 inhibitor FK3311 on ischemia-reperfusion injury in a canine total hepatic vascular exclusion model. J Am Coll Surg 192:54-62, 2001.
24. Novak TE, Babcock TA, Jho DH, Helton WS, Espat NJ: NF-.B inhibition by 5-3 fatty acids modulates LPS-stimulated macrophage TNF-! transcription. Am J Physiol Lung Cell Mol Physiol 284:L84-L89, 2003.
25. Colletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA Jr: Role of tumor necrosis factorY! in the pathophysiologic alterations after hepatic ischemia/reperfusion injury in the rat. J Clin Invest 85:1936-1943, 1990.
26. Wanner GA, Müller PEM, Ertel W, Bauer M, Menger MD, Messmer K: Differential effect of antiYTNF-! antibody on proinflammatory cytokine release by Kupffer cells following liver ischemia and reperfusion. Shock 11: 391-395, 1999.
27. Gauldie J, Richards C, Harnish D, Lansdorp P, Baumann H: Interferon "2/ B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 84:7251-7255, 1987.
28. Terajima H, Kondo T, Enders G, Hammer C, Thiery J, Yamamoto Y, Yamaoka Y, Messmer K: Reduction of hepatic microcirculatory failure caused by normothermic ischemia/reperfusion-induced injury by means of heat shock preconditioning. Shock 12:329-334, 1999.
29. Yokoyama Y, Nimura Y, Nagino M, Bland KI, Chaudry IH: Role of throm-boxane in producing hepatic injury during hepatic stress. Arch Surg 140: 801-807, 2005.
30. Armstrong GAB, Shoemarker KL, Money TGA, Robertson RM: Octopamine mediates thermal preconditioning of the locust ventilatory central pattern generator via a cAMP/protein kinase A signaling pathway. J Neurosci 26: 12118-12126, 2006.
31. Kume M, Banafsche R, Yamamoto Y, Yamaoka Y, Nobiling R, Gebhard M-M, Klar E: Dynamic changes of post-ischemic hepatic microcirculation improved by a pre-treatment of phosphodiesterase-3 inhibitor, milrinone. J Surg Res 136: 209-218, 2006.
32. Szentandrássy N, Pérez-Bido MR, Alonzo E, Negretti N, O'Neill SC: Protein kinase A is activated by the n-3 polyunsaturated fatty acid eicosapentaenoic acid in rat ventricular muscle. J Physiol 582:349-358, 2007.
33. Schmöcker C, Weylandt KH, Kahlke L, Wang J, Lobeck H, Tiegs G, Berg T, Kang JX: Omega-3 fatty acids alleviate chemically induced acute hepatitis by suppression of cytokines. Hepatology 45:864-869, 2007.
34. Schwab JM, Chiang N, Arita M, Serhan CN: Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447:869-874, 2007.